Capital deployed into deeptech
Deeptech expands the world of the possible
Long horizons.
Technical risk.
Markets that don’t exist yet.
Creating enduring businesses that change everything.
What we know
Groundbreaking science is the bedrock of great companies — but that is just where it starts.
- >£0 million
- >0
Portfolio companies backed
- £0 million
Capital returned to investors
Biggest exit
$1.5 billion
OrganOx achieved 19x multiple for Longwall fund investors
What we have learnt
We've watched great science stall for avoidable reasons: over‑engineered products, shaky foundations, optimistic forecasts, poor product‑market fit.
These are the traps.
We've seen enough to know how it works, when it works.
There is no one secret to success, but we've seen myriads of pitfalls to avoid.
Don't over-engineer
Simplifying is difficult. Don’t try to fill the gaps with features or applied theory. We push for elegant, business-smart solutions.
Design for success
We help to structure things right from the start to avoid surprises as you build.
Plan for the pivot
The first plan rarely survives contact with reality. We help you build the resilience to adapt.
Know the real cost
Founders underestimate time and cost. When you scale, so do the problems. Be ready.
WHAT WE BRING
Our know-how comes from >20 years of company-building.
Hardware, deeptech and hard science don’t fit technology venture timelines or playbooks.
We bring repeated experience of success in building hardware companies. We make connections across the UK deeptech ecosystem. And we have the patience to stay the course.
Focusing on the fundamentals
Know your customer, understand their pain, be capital efficient. We provide hands-on value-add beyond capital at the earliest stages and when it’s needed.
Creating durable operations
We provide frameworks, governance structures and practical processes for complex business challenges.
Supporting leadership with leadership
We’re willing to lead actively and engage deeply during the most critical moments.
Recognising risk of repeating patterns
Our long-term experience helps anticipate risks and provide guidance whilst nurturing the upside. We help our companies navigate out of challenges so they can get on with commercial building.
What we need
Companies we invest in have:
Valuable markets
Big enough margin sustaining opportunity for an exit to achieve target returns of at least ½ the fund or 10x the capital in a reasonable timeframe.
Unique technology with rich pivot and future development potential
Strong moats; applications that don’t require pushing up against limits of the possible; technical challenges that have risk but not fundamental uncertainty; and the potential for significant future development beyond initial applications.
Leadership that is close to its customers
We expect our companies to always be talking to their customers, understanding their workflows, their needs, their decision making, their constraints. Talk – then talk some more.
Capital requirements that suit our fund size
Potential to build lean, at least until the core business hypothesis is proven; and co-investors to help us build.
How we invest
Lead investor in early-stage IP-protected ventures at the edges of science and technology.
UK-centred and sector-specific
Complex solutions in: advanced manufacturing, life sciences, medical technologies, defence, clean energy, or adjacent sectors.
Pre-Seed or Seed
We back businesses without a proven market that have complicated development cycles.
Up to £1.5 M initial investment
We will lead from the start and follow on when you grow.